Distribution of CCR5-Δ32, CCR5m303A, CCR2-64I and SDF1-3′A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China

Infection, Genetics and Evolution

Volumn 10, Issue 2, 2010, Pages 268-272

  Tan, Xiao hua ^a,b   Zhang, Jing yu ^a   Di, Chun hong ^a   Hu, Ao rong ^a   Yang, Lei ^a,c   Qu, Shen ^c   Zhao, Rong li ^d   Yang, Pei rong ^a   Guo, Shu xia ^a  

^a SHIHEZI UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HANGZHOU NORMAL UNIVERSITY   (China)

^d Center of Disease Control of Yining City   (China)

Author keywords

CCR2 64I; CCR5 32; CCR5m303A; HIV 1; SDF1 3 A; Uighurs

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 DELTA32; CHEMOKINE RECEPTOR CCR5 M303A; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1 3'A; UNCLASSIFIED DRUG; CCR2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION LIGASE DETECTION REACTION; PRIORITY JOURNAL; CHI SQUARE DISTRIBUTION; CHINA; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PREVALENCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADOLESCENT; ADULT; CHEMOKINE CXCL12; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; RECEPTORS, CCR2; RECEPTORS, CCR5;

EID: 76849096026     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2009.11.015     Document Type: Article

References (48)

1. Adojaan M., Molder T., Mannik A., Kivisild T., Villems R., Krispin T., et al. High prevalence of the CCR5delta32 HIV-resistance mutation among estonian HIV type 1-infected individuals. AIDS Res. Hum. Retroviruses 23 (2007) 193
2. Apostolakis S., Baritaki S., Krambovitis E., and Spandidos D.A. Distribution of HIV/AIDS protective sdf1, CCR5 and CCR2 gene variants within cretan population. J. Clin. Virol. 34 (2005) 310
3. Balotta C., Bagnarelli P., Violin M., Ridolfo A.L., Zhou D., Berlusconi A., et al. Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. Aids 11 (1997) F67
4. Barany F. Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 189
5. Berger E.A., Murphy P.M., and Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17 (1999) 657
6. Biti R., Ffrench R., Young J., Bennetts B., Stewart G., and Liang T. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat. Med. 3 (1997) 252
7. Brambilla A., Villa C., Rizzardi G., Veglia F., Ghezzi S., Lazzarin A., et al. Shorter survival of sdf1-3′a/3′a homozygotes linked to cd4+ t cell decrease in advanced human immunodeficiency virus type 1 infection. J. Infect. Dis. 182 (2000) 311
8. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85 (1996) 1135
9. Choi B.S., Choi J.H., Kim S.S., Kee M.K., and Lee J.S. CCR2b-64i allelic polymorphisms in advanced HIV-infected koreans accelerate disease progression. AIDS Res. Hum. Retroviruses 23 (2007) 805
10. Easterbrook P.J., Rostron T., Ives N., Troop M., Gazzard B.G., and Rowland-Jones S.L. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. J. Infect. Dis. 180 (1999) 1096
11. Guerini F.R., Delbue S., Zanzottera M., Agliardi C., Saresella M., Mancuso R., et al. Analysis of CCR5, CCR2, sdf1 and rantes gene polymorphisms in subjects with HIV-related pml and not determined leukoencephalopathy. Biomed. Pharmacother. 62 (2008) 26
12. Hong W., Wang F., Jin L., Xing L., Liu M., Du Q., et al. Genotyping of HIV resistant alleles in indigenous tibetan ethnic group of china: low frequency of CCR5triangle32 and high frequency of CCR2b-64i alleles. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18 (2001) 268
13. Ioannidis J.P., Rosenberg P.S., Goedert J.J., Ashton L.J., Benfield T.L., Buchbinder S.P., et al. Effects of CCR5-delta32, CCR2-64i, and sdf-1 3′a alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann. Intern. Med. 135 (2001) 782
14. Jang D.H., Choi B.S., and Kim S.S. The effects of rantes/CCR5 promoter polymorphisms on HIV disease progression in HIV-infected koreans. Int. J. Immunogenet. 35 (2008) 101
15. Jlizi A., Edouard J., Fadhlaoui-Zid K., Frigi S., Debre P., Slim A., et al. Identification of the CCR5-delta32 HIV resistance allele and new mutations of the CCR5 gene in different tunisian populations. Hum. Immunol. 68 (2007) 993
16. Kalev I., Mikelsaar A.V., Beckman L., Tasa G., and Parlist P. High frequency of the HIV-1 protective CCR5 delta32 deletion in native estonians. Eur. J. Epidemiol. 16 (2000) 1107
17. Kaur G., Singh P., Rapthap C.C., Kumar N., Vajpayee M., Sharma S.K., et al. Polymorphism in the CCR5 gene promoter and HIV-1 infection in north indians. Hum. Immunol. 68 (2007) 454
18. Liu H., Nakayama E.E., Theodorou I., Nagai Y., Likanonsakul S., Wasi C., et al. Polymorphisms in CCR5 chemokine receptor gene in japan. Int. J. Immunogenet. 34 (2007) 325
19. McNamara D.T., Thomson J.M., Kasehagen L.J., and Zimmerman P.A. Development of a multiplex pcr-ligase detection reaction assay for diagnosis of infection by the four parasite species causing malaria in humans. J. Clin. Microbiol. 42 (2004) 2403
20. Mulherin S.A., O'Brien T.R., Ioannidis J.P., Goedert J.J., Buchbinder S.P., Coutinho R.A., et al. Effects of CCR5-delta32 and CCR2-64i alleles on HIV-1 disease progression: the protection varies with duration of infection. Aids 17 (2003) 377
21. Nookhai S., Ruxrungtham K., Phanuphak P., and Oelrichs R. Prevalence of CCR2-64i, sdf1-3′a and CCR5-delta32 alleles in healthy thais. Eur. J. Immunogenet. 27 (2000) 153
22. O'Brien T.R., Winkler C., Dean M., Nelson J.A., Carrington M., Michael N.L., et al. HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 349 (1997) 1219
23. Ometto L., Bertorelle R., Mainardi M., Giurisato M., Chieco-Bianchi L., and De Rossi A. Analysis of the cc chemokine receptor 5 m303 mutation in infants born to HIV-1-seropositive mothers. Aids 13 (1999) 871
24. Peng H., Xia Z.G., Fan S.Y., and Zhao S.Y. The epidemic characters and tendency of HIV/AIDS of sinkiang. Chin. J. Lab. Med. 28 (2005) 1151
25. Reiche E.M., Bonametti A.M., Voltarelli J.C., Morimoto H.K., and Watanabe M.A. Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infection (HIV-1). Curr. Med. Chem. 14 (2007) 1325
26. Rizzardi G.P., Morawetz R.A., Vicenzi E., Ghezzi S., Poli G., Lazzarin A., et al. CCR2 polymorphism and HIV disease. Swiss HIV cohort. Nat. Med. 4 (1998) 252
27. Roman F., Franck N., Burgy C., Servais J., Zimmer J.M., Mossong J., et al. Prevalence of HIV co-receptor polymorphisms in HIV-infected patients and uninfected volunteers in luxembourg. HIV Clin. Trials 3 (2002) 195
28. Salem A.H., and Batzer M.A. Distribution of the HIV resistance CCR5-delta32 allele among egyptians and syrians. Mutat. Res. 616 (2007) 175
29. Salem A.H., Farid E., et al. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3′A) in the Bahraini population. AIDS Res. Hum. Retroviruses 25 (2009) 973
30. Shieh B., Yan Y.P., Ko N.Y., Liau Y.E., Liu Y.C., Lin H.H., et al. Detection of elevated serum beta-chemokine levels in seronegative chinese individuals exposed to human immunodeficiency virus type 1. Clin. Infect. Dis. 33 (2001) 273
31. Smith M.W., Dean M., Carrington M., Winkler C., Huttley G.A., Lomb D.A., et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia growth and development study (hgds), multicenter aids cohort study (macs), multicenter hemophilia cohort study (mhcs), san francisco city cohort (sfcc), alive study. Science 277 (1997) 959
32. Su B., Jin L., Hu F., Xiao J., Luo J., Lu D., et al. Distribution of two HIV-1-resistant polymorphisms (sdf1-3′a and CCR2-64i) in east asian and world populations and its implication in aids epidemiology. Am. J. Hum. Genet. 65 (1999) 1047
33. Su B., Sun G., Lu D., Xiao J., Hu F., Chakraborty R., et al. Distribution of three HIV-1 resistance-conferring polymorphisms (sdf1-3′a, CCR2-641, and CCR5-delta32) in global populations. Eur. J. Hum. Genet. 8 (2000) 975
34. Suresh P., Wanchu A., Sachdeva R.K., and Bhatnagar A. Gene polymorphisms in CCR5, CCR2, cx3cr1, sdf-1 and rantes in exposed but uninfected partners of HIV-1 infected individuals in north india. J. Clin. Immunol. 26 (2006) 476
35. Tiensiwakul P. Stromal cell-derived factor (sdf) 1-3′a polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk thais. Intervirology 47 (2004) 87
36. van Rij R.P., de Roda Husman A.M., Brouwer M., Goudsmit J., Coutinho R.A., and Schuitemaker H. Role of CCR2 genotype in the clinical course of syncytium-inducing (si) or non-si human immunodeficiency virus type 1 infection and in the time to conversion to si virus variants. J. Infect. Dis. 178 (1998) 1806
37. Verma R., Gupta R.B., Singh K., Bhasin R., Anand Shukla A., Chauhan S.S., et al. Distribution of CCR5delta32, CCR2-64i and sdf1-3′a and plasma levels of sdf-1 in HIV-1 seronegative north indians. J. Clin. Virol. 38 (2007) 198
38. Voevodin A., Samilchuk E., and Dashti S. Frequencies of sdf-1 chemokine, CCR-5, and CCR-2 chemokine receptor gene alleles conferring resistance to human immunodeficiency virus type 1 and aids in kuwaitis. J. Med. Virol. 58 (1999) 54
39. Wang F., Jin L., Lei Z., Shi H., Hong W., Xu D., et al. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64i and sdf1-3′ a HIV-1 resistance alleles in indigenous han chinese. Chin. Med. J. (Engl.) 114 (2001) 1162
40. Wang F.S., Hong W.G., Cao Y., Liu M.X., Jin L., Hu L.P., et al. Population survey of CCR5 delta32, CCR5 m303, CCR2b 64i, and sdf1 3′a allele frequencies in indigenous chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups. J. Acquir. Immune Defic. Syndr. 32 (2003) 124
41. Wang S.X., Shang H., Han X.X., Zhang Z.N., Wang Y.N., Zhang M., et al. Variant genotyping of CCR2-64i, sdf1-3′ a and CCR5delta32 in HIV-1 infected chinese long-term nonprogressors. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 20 (2006) 16
42. Wang X.H., Feng T.J., Wang F.S., Chen L., Shi X.D., and Jin L. Effect of CCR5delta32, CCR5m303, CCR2-64i and sdf1-3′a gene polymorphism on the prognosis of chinese HIV-1 carriers. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 19 (2005) 256
43. Williamson C., Loubser S.A., Brice B., Joubert G., Smit T., Thomas R., et al. Allelic frequencies of host genetic variants influencing susceptibility to HIV-1 infection and disease in south african populations. Aids 14 (2000) 449
44. Winkler C., Modi W., Smith M.W., Nelson G.W., Wu X., Carrington M., et al. Genetic restriction of aids pathogenesis by an sdf-1 chemokine gene variant. Alive study, hemophilia growth and development study (hgds), multicenter aids cohort study (macs), multicenter hemophilia cohort study (mhcs), san francisco city cohort (sfcc). Science 279 (1998) 389
45. Xiao Y., Kristensen S., Sun J., Lu L., and Vermund S.H. Expansion of HIV/aids in china: lessons from yunnan province. Soc. Sci. Med. 64 (2007) 665
46. Yudin N.S., Vinogradov S.V., Potapova T.A., Naykova T.M., Sitnikova V.V., Kulikov I.V., et al. Distribution of CCR5-delta 32 gene deletion across the russian part of eurasia. Hum. Genet. 102 (1998) 695
47. Zhang L., Zhu J., Rui B., Zhang Y., Yin L., Ruan Y., et al. High HIV risk among uigur minority ethnic drug users in northwestern china. Trop. Med. Int. Health 13 (2008) 814
48. Zhang X.L., Zhang C.Y., Yu Y., Chen F., Li P., and Fu S.B. CCR2 allele polymorphisms in 15 chinese ethnic populations. Int. J. Immunogenet. 33 (2006) 45